Claritev Corporation (CTEV) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 146.9M | FY2026-Q1 |
| Levered Free Cash Flow | -92.5M | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 60.00 percent | FY2026-Q1 |
| Claim Charges Processed | 47.2B | FY2025-Q4 |
| Identified Potential Medical Cost Savings | 6.4B | FY2025-Q4 |
Back to CTEV overview · CTEV earnings · CTEV holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.